Mark S. Fineman

机构：University of Massachusetts Lowell · ORCID：0000-0002-9883-6847

发表论文 74 篇 · 总被引 11401 次 · h-index 39

代表论文

• Effects of Exenatide (Exendin-4) on Glycemic Control and Weight Over 30 Weeks in Metformin-Treated Patients With Type 2 Diabetes (2005 · Diabetes Care · 被引 1565)
• Effects of Exenatide (Exendin-4) on Glycemic Control Over 30 Weeks in Sulfonylurea-Treated Patients With Type 2 Diabetes (2004 · Diabetes Care · 被引 1350)
• Effects of Exenatide (Exendin-4) on Glycemic Control Over 30 Weeks in Patients With Type 2 Diabetes Treated With Metformin and a Sulfonylurea (2005 · Diabetes Care · 被引 1180)
• Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study (2012 · The Lancet · 被引 566)
• Effects of Once-Weekly Dosing of a Long-Acting Release Formulation of Exenatide on Glucose Control and Body Weight in Subjects With Type 2 Diabetes (2007 · Diabetes Care · 被引 447)
• Pharmacokinetics, pharmacodynamics, and safety of exenatide in patients with type 2 diabetes mellitus (2005 · American Journal of Health-System Pharmacy · 被引 439)